See on Scoop.it – Interesting Innovation
The Chancellor announced today that, as part of this year’s budget, the Catapult network will benefit from a £74m investment to focus on cell therapy manufacturing and graphene applications.
Ajan Reginald‘s insight:
Good to see this investment in the UK and good momentum with Cell Therapy Catapult.
However – perhaps worth remembering this level of commitment is dwarfed by California CIRM and Japanese initiatives.
See on www.innovateuk.org
